Key result
ZAP-S overexpression directly interacts with SARS-CoV-2 RNA and ribosomes, impairing frameshifting and reducing viral replication by more than 90%.
Why the study?
It was largely unknown how cellular factors alter the mechanical properties of frameshifting RNA molecules and impact virulence in viruses such as SARS-CoV-2.
ZAP-S is a host-encoded specific inhibitor of SARS-CoV-2 programmed ribosomal frameshifting that strongly impairs viral replication in vitro.
No immediate clinical implications for COVID-19; leaves open ZAP-S as a host antiviral target pending further validation.
Programmed ribosomal frameshifting (PRF) is a fundamental gene expression event in many viruses including SARS-CoV-2, which allows production of essential structural and replicative enzymes from an alternative reading frame. Despite the importance of PRF for the viral life cycle, it is still largely unknown how and to what extent cellular factors alter mechanical properties of frameshifting RNA molecules and thereby impact virulence. This prompted us to comprehensively dissect the interplay between the host proteome and the SARS-CoV-2 frameshift element. Here, we reveal that zinc-finger antiviral protein (ZAP-S) is a direct and specific regulator of PRF in SARS-CoV-2 infected cells. ZAP-S overexpression strongly impairs frameshifting and viral replication. Using in vitro ensemble and single-molecule techniques, we further demonstrate that ZAP-S directly interacts with the SARS-CoV-2 RNA and ribosomes and interferes with the folding of the frameshift RNA. Together these data illuminate ZAP-S as de novo host-encoded specific inhibitor of SARS-CoV-2 frameshifting and expand our understanding of RNA-based gene regulation.
No takes yet. Share an insight, caveat, or question.
Zimmer et al. (2021) studied SARS-CoV-2 infection. ZAP-S overexpression vs. Control was evaluated on SARS-CoV-2 viral replication. ZAP-S overexpression directly interacts with SARS-CoV-2 RNA and ribosomes, impairing frameshifting and reducing viral replication by more than 90%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: